Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Undertreatment of nausea and other symptoms in hospitalized cancer patients

    Access Status
    Fulltext not available
    Authors
    Greaves, J.
    Glare, P.
    Kristjanson, Linda
    Stockler, M.
    Tattersall, M.
    Date
    2009
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Greaves, Judi and Glare, Paul and Kristjanson, Linda and Stockler, M. and Tattersall, M. 2009. Undertreatment of nausea and other symptoms in hospitalized cancer patients. Supportive Care in Cancer. 17 (4): pp. 461-464.
    Source Title
    Supportive Care in Cancer
    DOI
    10.1007/s00520-008-0511-4
    ISSN
    09414355
    Faculty
    School of Nursing and Midwifery
    Faculty of Health Sciences
    Western Australian Centre for Cancer and Palliative Care (WACCP)
    School
    WA Centre for Cancer and Palliative Care (WACCPC)
    Remarks

    The original publication is available at: http://www.springerlink.com

    URI
    http://hdl.handle.net/20.500.11937/14768
    Collection
    • Curtin Research Publications
    Abstract

    Objective This survey aimed to provide a symptom profile, in particular for nausea and its treatment, of advanced cancer patients prior to implementation of a clinical practice guideline for nausea. Materials and methods An audit of 82 advanced cancer patients admitted to a major Australian teaching hospital was undertaken. While nausea was present in 26 (32%) of respondents, antiemetics were prescribed in 52 (68%), a higher proportion than in the past, and being taken by 32 (39%). Results and conclusion Patients reporting moderate-to-severe nausea often missed out on treatment. These findings underscore the need for more attention to education of hospital staff in the assessment and treatment of this frequently bothersome symptom, and raise issues for study design of symptom control research.

    Related items

    Showing items related by title, author, creator and subject.

    • Unplanned oncology admissions within 14 days of non-surgical discharge: a retrospective study
      Gibson, S.; McConigley, Ruth (2015)
      © 2015 Springer-Verlag Berlin Heidelberg Aim: The aim of this study was to identify the incidence, causes, risk factors and interventions for cancer patients requiring unplanned admissions within 14 days of discharge at ...
    • Differences in mortality in acute coronary syndrome symptom clusters
      Riegel, B.; Hanlon, A.; McKinley, S.; Moser, D.; Meischke, H.; Doering, L.; Davidson, Patricia; Pelter, M.; Dracup, K. (2010)
      Background: The timely and accurate identification of symptoms of acute coronary syndrome (ACS) is a challenge forpatients and clinicians. It is unknown whether response times and clinical outcomes differ with specific ...
    • Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
      Chan, Arlene; Delaloge, S.; Holmes, F.; Moy, B.; Iwata, H.; Harvey, V.; Robert, N.; Silovski, T.; Gokmen, E.; von Minckwitz, G.; Ejlertsen, B.; Chia, S.; Mansi, J.; Barrios, C.; Gnant, M.; Buyse, M.; Gore, I.; Smith, J.; Harker, G.; Masuda, N.; Petrakova, K.; Zotano, A.; Iannotti, N.; Rodriguez, G.; Tassone, P.; Wong, A.; Bryce, R.; Ye, Y.; Yao, B.; Martin, M. (2016)
      Background: Neratinib, an irreversible tyrosine-kinase inhibitor of HER1, HER2, and HER4, has clinical activity in patients with HER2-positive metastatic breast cancer. We aimed to investigate the efficacy and safety of ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.